Interferon-β and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell derived clones rather than that of T3+ clones

R. J. van de Griend, C. P. Ronteltap, C. Gravekamp, D. Monnikendam, R. L. Bolhuis

Research output: Contribution to journal › Article › peer-review

32 Scopus citations

Fingerprint

Dive into the research topics of 'Interferon-β and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell derived clones rather than that of T3+ clones'. Together they form a unique fingerprint.

Medicine & Life Sciences